Search

everythinglearnresearchcommunity

for

Search:↓

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Platelet-rich plasma (PRP) shows promise in military medicine but its effectiveness varies.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Combining physical dermabrasion with chemical peeling is more effective for skin treatment than chemical peeling alone.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.